Logo image of DOCN

DIGITALOCEAN HOLDINGS INC (DOCN) Stock Fundamental Analysis

NYSE:DOCN - US25402D1028 - Common Stock

31.53 USD
+1.54 (+5.14%)
Last: 8/22/2025, 8:04:00 PM
31.526 USD
0 (-0.01%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, DOCN scores 5 out of 10 in our fundamental rating. DOCN was compared to 83 industry peers in the IT Services industry. Both the profitability and the financial health of DOCN get a neutral evaluation. Nothing too spectacular is happening here. DOCN is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DOCN had positive earnings in the past year.
DOCN had a positive operating cash flow in the past year.
In multiple years DOCN reported negative net income over the last 5 years.
Each year in the past 5 years DOCN had a positive operating cash flow.
DOCN Yearly Net Income VS EBIT VS OCF VS FCFDOCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

DOCN has a better Return On Assets (7.35%) than 75.90% of its industry peers.
With a decent Return On Invested Capital value of 6.93%, DOCN is doing good in the industry, outperforming 62.65% of the companies in the same industry.
Industry RankSector Rank
ROA 7.35%
ROE N/A
ROIC 6.93%
ROA(3y)1.65%
ROA(5y)-1.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DOCN Yearly ROA, ROE, ROICDOCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

DOCN's Profit Margin of 15.18% is amongst the best of the industry. DOCN outperforms 91.57% of its industry peers.
DOCN has a better Operating Margin (15.66%) than 85.54% of its industry peers.
With an excellent Gross Margin value of 59.67%, DOCN belongs to the best of the industry, outperforming 80.72% of the companies in the same industry.
In the last couple of years the Gross Margin of DOCN has grown nicely.
Industry RankSector Rank
OM 15.66%
PM (TTM) 15.18%
GM 59.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y2.79%
DOCN Yearly Profit, Operating, Gross MarginsDOCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOCN is destroying value.
The number of shares outstanding for DOCN has been increased compared to 1 year ago.
Compared to 5 years ago, DOCN has more shares outstanding
DOCN has a better debt/assets ratio than last year.
DOCN Yearly Shares OutstandingDOCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DOCN Yearly Total Debt VS Total AssetsDOCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.65, we must say that DOCN is in the distress zone and has some risk of bankruptcy.
DOCN has a worse Altman-Z score (1.65) than 63.86% of its industry peers.
DOCN has a debt to FCF ratio of 15.86. This is a negative value and a sign of low solvency as DOCN would need 15.86 years to pay back of all of its debts.
DOCN has a Debt to FCF ratio (15.86) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.86
Altman-Z 1.65
ROIC/WACC0.95
WACC7.32%
DOCN Yearly LT Debt VS Equity VS FCFDOCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

DOCN has a Current Ratio of 2.27. This indicates that DOCN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.27, DOCN is in the better half of the industry, outperforming 69.88% of the companies in the same industry.
A Quick Ratio of 2.27 indicates that DOCN has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.27, DOCN is doing good in the industry, outperforming 69.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 2.27
DOCN Yearly Current Assets VS Current LiabilitesDOCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.67% over the past year.
DOCN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 145.35% yearly.
DOCN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.29%.
DOCN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.09% yearly.
EPS 1Y (TTM)20.67%
EPS 3Y145.35%
EPS 5YN/A
EPS Q2Q%22.92%
Revenue 1Y (TTM)13.29%
Revenue growth 3Y22.13%
Revenue growth 5Y25.09%
Sales Q2Q%13.62%

3.2 Future

DOCN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.16% yearly.
DOCN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.41% yearly.
EPS Next Y3.46%
EPS Next 2Y4.36%
EPS Next 3Y10.16%
EPS Next 5YN/A
Revenue Next Year13.59%
Revenue Next 2Y13.84%
Revenue Next 3Y14.55%
Revenue Next 5Y13.41%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DOCN Yearly Revenue VS EstimatesDOCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
DOCN Yearly EPS VS EstimatesDOCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

DOCN is valuated correctly with a Price/Earnings ratio of 14.60.
Based on the Price/Earnings ratio, DOCN is valued a bit cheaper than the industry average as 79.52% of the companies are valued more expensively.
DOCN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.24.
DOCN is valuated correctly with a Price/Forward Earnings ratio of 15.08.
Based on the Price/Forward Earnings ratio, DOCN is valued a bit cheaper than the industry average as 69.88% of the companies are valued more expensively.
DOCN is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.6
Fwd PE 15.08
DOCN Price Earnings VS Forward Price EarningsDOCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as DOCN.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DOCN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 30.57
EV/EBITDA 14.88
DOCN Per share dataDOCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DOCN does not grow enough to justify the current Price/Earnings ratio.
DOCN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.22
PEG (5Y)N/A
EPS Next 2Y4.36%
EPS Next 3Y10.16%

0

5. Dividend

5.1 Amount

No dividends for DOCN!.
Industry RankSector Rank
Dividend Yield N/A

DIGITALOCEAN HOLDINGS INC

NYSE:DOCN (8/22/2025, 8:04:00 PM)

After market: 31.526 0 (-0.01%)

31.53

+1.54 (+5.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/amc
Inst Owners65.32%
Inst Owner Change5.6%
Ins Owners0.95%
Ins Owner Change0.14%
Market Cap2.87B
Analysts77
Price Target39.02 (23.76%)
Short Float %12.38%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.75%
Min EPS beat(2)23.58%
Max EPS beat(2)23.93%
EPS beat(4)4
Avg EPS beat(4)28.77%
Min EPS beat(4)23.58%
Max EPS beat(4)41.38%
EPS beat(8)8
Avg EPS beat(8)22.77%
EPS beat(12)11
Avg EPS beat(12)23.98%
EPS beat(16)14
Avg EPS beat(16)25.95%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.01%
Max Revenue beat(2)-0.95%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-1.07%
Max Revenue beat(4)0.2%
Revenue beat(8)3
Avg Revenue beat(8)-0.44%
Revenue beat(12)4
Avg Revenue beat(12)-0.65%
Revenue beat(16)5
Avg Revenue beat(16)-0.75%
PT rev (1m)0%
PT rev (3m)-8.02%
EPS NQ rev (1m)3.67%
EPS NQ rev (3m)-0.59%
EPS NY rev (1m)0%
EPS NY rev (3m)1.48%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 14.6
Fwd PE 15.08
P/S 3.45
P/FCF 30.57
P/OCF 9.53
P/B N/A
P/tB N/A
EV/EBITDA 14.88
EPS(TTM)2.16
EY6.85%
EPS(NY)2.09
Fwd EY6.63%
FCF(TTM)1.03
FCFY3.27%
OCF(TTM)3.31
OCFY10.5%
SpS9.15
BVpS-1.92
TBVpS-6.96
PEG (NY)4.22
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.35%
ROE N/A
ROCE 8.72%
ROIC 6.93%
ROICexc 9.36%
ROICexgc 15.96%
OM 15.66%
PM (TTM) 15.18%
GM 59.67%
FCFM 11.27%
ROA(3y)1.65%
ROA(5y)-1.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y2.79%
F-Score7
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.86
Debt/EBITDA 5.79
Cap/Depr 163.25%
Cap/Sales 24.9%
Interest Coverage 179.62
Cash Conversion 117.02%
Profit Quality 74.24%
Current Ratio 2.27
Quick Ratio 2.27
Altman-Z 1.65
F-Score7
WACC7.32%
ROIC/WACC0.95
Cap/Depr(3y)124.77%
Cap/Depr(5y)130.2%
Cap/Sales(3y)21.36%
Cap/Sales(5y)25.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.67%
EPS 3Y145.35%
EPS 5YN/A
EPS Q2Q%22.92%
EPS Next Y3.46%
EPS Next 2Y4.36%
EPS Next 3Y10.16%
EPS Next 5YN/A
Revenue 1Y (TTM)13.29%
Revenue growth 3Y22.13%
Revenue growth 5Y25.09%
Sales Q2Q%13.62%
Revenue Next Year13.59%
Revenue Next 2Y13.84%
Revenue Next 3Y14.55%
Revenue Next 5Y13.41%
EBIT growth 1Y63.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.62%
EBIT Next 3Y33.49%
EBIT Next 5Y25.38%
FCF growth 1Y-10.19%
FCF growth 3Y58.83%
FCF growth 5YN/A
OCF growth 1Y37.51%
OCF growth 3Y28.54%
OCF growth 5Y47.94%